These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29452886)

  • 21. Tear film change and ocular symptoms after reading printed book and electronic book: a crossover study.
    Prabhasawat P; Pinitpuwadol W; Angsriprasert D; Chonpimai P; Saiman M
    Jpn J Ophthalmol; 2019 Mar; 63(2):137-144. PubMed ID: 30604111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors predicting the ocular surface response to desiccating environmental stress.
    Alex A; Edwards A; Hays JD; Kerkstra M; Shih A; de Paiva CS; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3325-32. PubMed ID: 23572103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the clinical effects of carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: a 4-week, prospective, open-label, randomized, parallel-group, noninferiority study.
    Wang TJ; Wang IJ; Ho JD; Chou HC; Lin SY; Huang MC
    Clin Ther; 2010 Jan; 32(1):44-52. PubMed ID: 20171410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of a panel for dry-eye protein biomarkers in tears: A comparative pilot study using standard ELISA and customized microarrays.
    Benitez-Del-Castillo JM; Soria J; Acera A; Muñoz AM; Rodríguez S; Suárez T
    Mol Vis; 2021; 27():243-261. PubMed ID: 34012227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response profiles to a controlled adverse desiccating environment based on clinical and tear molecule changes.
    Fernández I; López-Miguel A; Enríquez-de-Salamanca A; Tesón M; Stern ME; González-García MJ; Calonge M
    Ocul Surf; 2019 Jul; 17(3):502-515. PubMed ID: 30936038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous serum eye drops for dry eye.
    Pan Q; Angelina A; Marrone M; Stark WJ; Akpek EK
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009327. PubMed ID: 28245347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relief of dry eye signs and symptoms using a combination of lubricants, lid hygiene and ocular nutraceuticals.
    Ngo W; Srinivasan S; Houtman D; Jones L
    J Optom; 2017; 10(1):26-33. PubMed ID: 27425263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of CCR5 and its ligands CCL3, -4, and -5 in the tear film and ocular surface of patients with dry eye disease.
    Choi W; Li Z; Oh HJ; Im SK; Lee SH; Park SH; You IC; Yoon KC
    Curr Eye Res; 2012 Jan; 37(1):12-7. PubMed ID: 22029739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of tear osmolarity and tear function in patients with Behçet's syndrome.
    Aktaş S; Temiztürk F
    Can J Ophthalmol; 2019 Apr; 54(2):176-179. PubMed ID: 30975340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated Measurement of Tear Film Dynamics and Lipid Layer Thickness for Assessment of Non-Sjögren Dry Eye Syndrome With Meibomian Gland Dysfunction.
    Ji YW; Lee J; Lee H; Seo KY; Kim EK; Kim TI
    Cornea; 2017 Feb; 36(2):176-182. PubMed ID: 28060064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of moderate-to-severe dry eye disease using chitosan-N-acetylcysteine (Lacrimera®) eye drops: a retrospective case series.
    Nepp J; Knoetzl W; Prinz A; Hoeller S; Prinz M
    Int Ophthalmol; 2020 Jun; 40(6):1547-1552. PubMed ID: 32124131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of the IL-33/ST2 pathway in dry eye.
    Wang S; Zhang H
    Mol Vis; 2019; 25():583-592. PubMed ID: 31673224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical cyclosporine A therapy for dry eye syndrome.
    de Paiva CS; Pflugfelder SC; Ng SM; Akpek EK
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD010051. PubMed ID: 31517988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and functional changes in corneal innervation after laser in situ keratomileusis and their relationship with dry eye.
    Chao C; Stapleton F; Zhou X; Chen S; Zhou S; Golebiowski B
    Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):2029-39. PubMed ID: 26259635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tear fluid plasmin activity of dry eye patients with Sjögren's syndrome.
    Virtanen T; Konttinen YT; Honkanen N; Härkönen M; Tervo T
    Acta Ophthalmol Scand; 1997 Apr; 75(2):137-41. PubMed ID: 9197558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The thickness of the human precorneal tear film: evidence from reflection spectra.
    King-Smith PE; Fink BA; Fogt N; Nichols KK; Hill RM; Wilson GS
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3348-59. PubMed ID: 11006224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tear evaluation by anterior segment OCT in dry eye disease.
    Diana MP; Ana B
    Rom J Ophthalmol; 2021; 65(1):25-30. PubMed ID: 33817430
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of insulin in the tear film and insulin receptor and IGF-1 receptor on the human ocular surface.
    Rocha EM; Cunha DA; Carneiro EM; Boschero AC; Saad MJ; Velloso LA
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):963-7. PubMed ID: 11923235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential Diagnosis of Sjögren Versus Non-Sjögren Dry Eye Through Tear Film Biomarkers.
    Akpek EK; Wu HY; Karakus S; Zhang Q; Masli S
    Cornea; 2020 Aug; 39(8):991-997. PubMed ID: 32195754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ω-3 Tear Film Lipids Correlate With Clinical Measures of Dry Eye.
    Walter SD; Gronert K; McClellan AL; Levitt RC; Sarantopoulos KD; Galor A
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2472-8. PubMed ID: 27138739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.